The adaptive stroma joining the antiangiogenic resistance front
J Clin Invest. 2011 Apr;121(4):1244-7. doi: 10.1172/JCI46430.…
Small molecule enoxacin is a cancer-specific growth inhibitor that acts by enhancing TAR RNA-binding protein 2-mediated microRNA processing
Proc Natl Acad Sci U S A. 2011 Mar 15;108(11):4394-9. doi: 10.1073/pnas.1014720108.…
The use of caspase inhibitors in pulsed-field gel electrophoresis may improve the estimation of radiation-induced DNA repair and apoptosis
Radiat Oncol. 2011 Jan 15;6:6. doi: 10.1186/1748-717X-6-6.ABSTRACTBACKGROUND:…
Filamin B plays a key role in vascular endothelial growth factor-induced endothelial cell motility through its interaction with Rac-1 and Vav-2
J Biol Chem. 2010 Apr 2;285(14):10748-60. doi: 10.1074/jbc.M109.062984.…
Sunitinib inhibits tumor growth and synergizes with cisplatin in orthotopic models of cisplatin-sensitive and cisplatin-resistant human testicular germ cell tumors
Clin Cancer Res. 2009 May 15;15(10):3384-95. doi: 10.1158/1078-0432.CCR-08-2170.…
Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis
Cancer Cell. 2009 Mar 3;15(3):220-31. doi: 10.1016/j.ccr.2009.01.027.ABSTRACTMultiple…
Antiangiogenic effect of gemcitabine following metronomic administration in a pancreas cancer model
Mol Cancer Ther. 2008 Mar;7(3):638-47. doi: 10.1158/1535-7163.MCT-07-2122.ABSTRACTGemcitabine…
New drug development in digestive neuroendocrine tumors
Ann Oncol. 2007 Aug;18(8):1307-13. doi: 10.1093/annonc/mdm009.…
Drug resistance by evasion of antiangiogenic targeting of VEGF signaling in late-stage pancreatic islet tumors
Cancer Cell. 2005 Oct;8(4):299-309. doi: 10.1016/j.ccr.2005.09.005.ABSTRACTFunction-blocking…
How to define intermediate stage in Hodgkin’s lymphoma?
Eur J Haematol Suppl. 2005 Jul;(66):111-4. doi: 10.1111/j.1600-0609.2005.00463.x.ABSTRACTBACKGROUND:…
Incomplete inhibition of the Rb tumor suppressor pathway in the context of inactivated p53 is sufficient for pancreatic islet tumorigenesis
Oncogene. 2005 Oct 6;24(44):6597-604. doi: 10.1038/sj.onc.1208823.ABSTRACTHere,…
P38SAPK2 phosphorylates cyclin D3 at Thr-283 and targets it for proteasomal degradation
Oncogene. 2004 Sep 30;23(45):7537-44. doi: 10.1038/sj.onc.1208040.ABSTRACTCyclin…
